Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Quality & Risk

    Management Representative

    In one line
    Member of management appointed to ensure QMS processes are established and report on QMS performance.
    Definition
    Required by ISO 13485 §5.5.2 and 21 CFR 820.20(b)(3), the management representative has explicit authority to ensure QMS effectiveness and to escalate issues to top management. Beyond escalation, the role reports on QMS performance and improvement needs and promotes awareness of regulatory and customer requirements. Under the QMSR it is carried through ISO 13485 clause 5.5.2 rather than the old 820.20(b)(3). It differs from the EU MDR's person responsible for regulatory compliance, though small companies sometimes give both roles to one person.
    Why it matters
    Often confused with the Quality VP - the role is about authority and reporting line, not title.
    Common pitfalls
    • •A common pitfall is conflating the Management Representative role with a specific job title, such as Quality VP, rather than focusing on the required authority and responsibilities.
    • •Failing to grant the Management Representative sufficient independence or direct access to top management can undermine the effectiveness of the role and QMS oversight.
    • •Inadequate documentation of the Management Representative's appointment, responsibilities, and authority can lead to non-conformities during audits.
    • •Assuming the Management Representative is solely responsible for all quality matters, rather than promoting a company-wide culture of quality, is a common misconception.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.